Claudin-18 isoform 2 (CLDN18.2) has emerged as a promising therapeutic target in gastric or gastro-oesophageal junction cancer. Satricabtagene autoleucel (satri-cel; also known as CT041), an ...

The reconstruction of bone usually depends on substitute transplantation, which has drawbacks including the limited bone substitutes available, comorbidity, immune rejection, and limited endogenous ...

Here, we developed a label-free, high-throughput Raman-activated cell sorting technology (pDEP-DLD-RACS) that enables rapid screening of metabolic traits from highly heterogeneous mutant libraries. By ...